Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Pozycja w akcjach #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Cena akcji
$4.00
Ostatnia synchronizacja: 2026-08-20
Kapitalizacja rynkowa
$75.37M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
12.99%
Kraj
US
Handel RetinalGenix Technologies Inc. (RTGN)

Kategoria

Wskaźnik P/S dla RetinalGenix Technologies Inc. (RTGN)
Wskaźnik P/S na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji RetinalGenix Technologies Inc., obecny wskaźnik P/S (TTM) wynosi 0. Na koniec 2026 wynosił 0.
Historia wskaźnika P/S dla RetinalGenix Technologies Inc. od 2026 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
Za mało danych dla podanych dat.
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
4.13 -
US
5.03 -
US
2.78 -
IE
3.67 -
US
- -
DE